Phase II Study of AP0302 5% Versus a Vehicle Comparator
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the analgesic safety and efficacy of study drug (AP0302)
applied topically every 6 hours as compared to a vehicle, in subjects experiencing delayed
onset muscle soreness.